These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4930898)

  • 1. [Clinical evaluation of a new gastroenterotrophic, spasmolytic and antacid combination (Gefarmil compositum)].
    Rovera R; Furlotti MG
    Minerva Gastroenterol; 1970; 16(4):191-8. PubMed ID: 4930898
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antacid effect of a magnesium trisilicate-1-hyoscyamine combination preparation (Neoplex B)--clinical and function analytical studies].
    Piaty R
    Wien Med Wochenschr; 1968 Feb; 118(8):157-9. PubMed ID: 4301560
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the antacid activity of K 3717 compound, using pH radiotelemetry].
    Arullani P
    Minerva Gastroenterol; 1971; 17(1):14-20. PubMed ID: 5569277
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical use of prifinium bromide: a new spasmolytic agent].
    Marini U; Spotti D; Visconti P
    Clin Ter; 1978 Nov; 87(4):367-74. PubMed ID: 36254
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinico-experimental study of an antacid with buffering effect].
    Bianchi PG; Saccabusi E
    Clin Ter; 1975 Jul; 74(1):13-34. PubMed ID: 770053
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial of an antacid dressing in eso-gastro-duodenal pathology].
    Bouali AB; Joubaud F
    Med Chir Dig; 1975; 4(2):127-31. PubMed ID: 1100939
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experimentation with pentanobornamide, a new synthetic spasmolytic].
    Miracco A; Peluso C
    Clin Ter; 1970 Mar; 52(6):557-63. PubMed ID: 4916457
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychotropic-anticholinergic management of gastrointestinal disorders.
    Weiss J; Weiss S
    Curr Ther Res Clin Exp; 1969 Jul; 11(7):436-46. PubMed ID: 4979992
    [No Abstract]   [Full Text] [Related]  

  • 9. [Review and study of the immediate results of medical treatment of 283 patients with various esophageal-gastrointestinal processes].
    Martínez Obrador D; Balanza Ortíz E
    Rev Esp Enferm Apar Dig; 1972 Mar; 36(6):735-52. PubMed ID: 5017112
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled evaluation of a new synthetic spasmolytic (DA 3177) in/pathology of the digestive system].
    Battocchio F; Negri L; Tacchettti G
    Clin Ter; 1979 Jun; 89(6):601-10. PubMed ID: 397029
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study of a protective medication in gastroduodenal pathology].
    Cachin M
    Therapeutique; 1969 Dec; 45(10):985-6. PubMed ID: 5386103
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical observations with a new analgesic-spasmolytic combination].
    Balthazar JA; Leite EM
    Hospital (Rio J); 1969 Jun; 75(6):2171-7. PubMed ID: 5311475
    [No Abstract]   [Full Text] [Related]  

  • 13. [DA 3177 a new synthetic spasmolytic agent in the management of spastic-dyskinetic conditions of the digestive tract. Double-blind controlled clinical trial].
    Bonzi G; Reguzzoni G; Rocca F; Negri L
    Clin Ter; 1979 Apr; 89(2):187-96. PubMed ID: 385213
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of pulgitherapy in current medical practice].
    Beauchet D
    Therapeutique; 1970 May; 46():52-4. PubMed ID: 5427189
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinical evaluation of a new concentrated antacid. II. Safety and efficacy in duodenal ulcer patients.
    Powell RL; Westlake WJ; Longaker ED; Greene LC
    J Clin Pharmacol New Drugs; 1971; 11(4):296-300. PubMed ID: 4932746
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trials of a combination of an original gastric demulcent and a synthetic anticholinergic agent].
    Evreux M; Jenoudet L
    Lyon Med; 1972 Jun; 227(11):1181-4. PubMed ID: 4564809
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of a new digestivo-spasmolytic agent].
    Glassman J; Odzak A
    Prensa Med Argent; 1966 Sep; 53(37):2033-5. PubMed ID: 5993479
    [No Abstract]   [Full Text] [Related]  

  • 18. [65 cases of upper digestive diseases treated with gastropulgite].
    Bel A; Prost G; Rubet A; Girard M
    Therapeutique; 1970 May; 46():39-46. PubMed ID: 5427187
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trial of an original antalgic and antispasmodic combination in gastroenterology].
    Phelip E; Martin P; Piante M; Lambert R
    Lyon Med; 1969 Sep; 222(32):323-7. PubMed ID: 5398818
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of a new antalgic-antispasmodic combination in gastroenterologic practice].
    Valla A; Verwaerde JC
    Therapeutique; 1969 Oct; 45(8):769-73. PubMed ID: 5386087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.